Neisseria Meningitidis Infection - 25 Studies Found Completed : Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. : Meningococcal Disease : 2014-05-15 : Biological: rMenB+OMV 2 doses of vaccine 2 months apart Active, not recruiting : MenPF-1 - A New Vaccine Against Meningococcal Disease : Serogroup B Meningococcal Disease : 2012-05-23 : Biological: MenPF-1. A new vaccine against meningococcal disease. Completed : Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months : Meningococcal Disease : 2008-01-15 : Biological: MenACWY-CRM197 Blo Completed : Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants : Meningococcal Disease : 2007-02-09 : Biological: rMenB One dose (0. Completed : Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents : Meningococcal Disease : 2006-02-27 : Biological: serogroup B meningococcal vaccine Completed : Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age. : Meningococcal Disease : 2012-09-07 : Biological: MenACWY-CRM The investigational meningococcal (groups A, C, Y, and W-135 vaccine) oligosacch Completed : Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers : Meningococcal Disease : 2013-11-11 : Biological: MenACWY-CRM MenACW Completed : Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults : Meningococcal Disease : 2007-11-16 : Biological: Men ACWY CRM A sin Completed : B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants : Meningococcal Disease : 2007-06-19 : Biological: MenACWY-CRM One do Withdrawn : A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger : Meningococcal Disease : 2011-02-08 Next >>>